Showing results (51-60 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|April 2, 2003
G-protein beta(3) subunit 825 C/T polymorphism is associated with weight gain during pregnancyVictor Dishy, Simi Gupta, Ruth Landau, et al.
Pharmacogenetics|February 24, 2001
Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patientsB Niesler, B Weiss, C Fischer, et al.
Pharmacogenetics|February 24, 2001
Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?R Løvlie, A K Daly, G E Matre, et al.
Pharmacogenetics|February 24, 2001
Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjectsE J Carlini, R B Raftogianis, T C Wood, et al.
Pharmacogenetics|February 24, 2001
Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjectsS A Vaziri, N C Hughes, H Sampson, et al.
Pharmacogenetics|February 24, 2001
Polymorphisms in the human paraoxonase (PON1) promoterV H Brophy, M D Hastings, J B Clendenning, et al.
Pharmacogenetics|February 18, 1999
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancersC Matthias, U Bockmühl, V Jahnke, et al.
Pharmacogenetics|January 1, 1995
Primary structures and properties of two related forms of aryl sulfotransferases in human liverS Ozawa, K Nagata, M Shimada, et al.
Pharmacogenetics|January 1, 1995
Genetic polymorphisms and susceptibility to cancer developmentT Sugimura, R Inoue, H Ohgaki, et al.
Pharmacogenetics|January 1, 1995
Molecular biomarkers for aflatoxins and their application to human liver cancerP Scholl, S M Musser, T W Kensler, et al.
Pageof 83